nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0304	0.032	CbGpPWpGaD
Tolazoline—HRH2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0259	0.0273	CbGpPWpGaD
Tolazoline—HRH2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0251	0.0265	CbGpPWpGaD
Tolazoline—HRH2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0234	0.0247	CbGpPWpGaD
Tolazoline—HRH2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0218	0.0229	CbGpPWpGaD
Tolazoline—HRH2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0211	0.0222	CbGpPWpGaD
Tolazoline—HRH2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0197	0.0207	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0179	0.0188	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0167	0.0176	CbGpPWpGaD
Tolazoline—HRH2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0164	0.0173	CbGpPWpGaD
Tolazoline—ADRA2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0152	0.016	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0149	0.0156	CbGpPWpGaD
Tolazoline—ADRA2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0148	0.0156	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0146	0.0154	CbGpPWpGaD
Tolazoline—ADRA2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0142	0.015	CbGpPWpGaD
Tolazoline—ADRA2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0138	0.0145	CbGpPWpGaD
Tolazoline—HRH2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0138	0.0145	CbGpPWpGaD
Tolazoline—ADRA2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0138	0.0145	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0136	0.0143	CbGpPWpGaD
Tolazoline—ADRA2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0129	0.0135	CbGpPWpGaD
Tolazoline—ADRA2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0128	0.0135	CbGpPWpGaD
Tolazoline—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0127	0.0133	CbGpPWpGaD
Tolazoline—Phentermine—SLC6A3—Gilles de la Tourette syndrome	0.0124	0.25	CrCbGaD
Tolazoline—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0124	0.0131	CbGpPWpGaD
Tolazoline—ADRA2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0124	0.0131	CbGpPWpGaD
Tolazoline—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0123	0.013	CbGpPWpGaD
Tolazoline—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0121	0.0127	CbGpPWpGaD
Tolazoline—ADRA2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.012	0.0126	CbGpPWpGaD
Tolazoline—Dextroamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.0119	0.238	CrCbGaD
Tolazoline—ADRA2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0116	0.0122	CbGpPWpGaD
Tolazoline—ADRA2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0116	0.0122	CbGpPWpGaD
Tolazoline—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0116	0.0122	CbGpPWpGaD
Tolazoline—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0115	0.0121	CbGpPWpGaD
Tolazoline—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0113	0.0118	CbGpPWpGaD
Tolazoline—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0112	0.0118	CbGpPWpGaD
Tolazoline—ADRA2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0108	0.0114	CbGpPWpGaD
Tolazoline—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0107	0.0112	CbGpPWpGaD
Tolazoline—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0105	0.011	CbGpPWpGaD
Tolazoline—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0105	0.011	CbGpPWpGaD
Tolazoline—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0103	0.0109	CbGpPWpGaD
Tolazoline—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0102	0.0107	CbGpPWpGaD
Tolazoline—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00972	0.0102	CbGpPWpGaD
Tolazoline—ADRA2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00965	0.0102	CbGpPWpGaD
Tolazoline—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00964	0.0101	CbGpPWpGaD
Tolazoline—Amphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00957	0.192	CrCbGaD
Tolazoline—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00946	0.00995	CbGpPWpGaD
Tolazoline—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00943	0.00993	CbGpPWpGaD
Tolazoline—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00901	0.00949	CbGpPWpGaD
Tolazoline—Methamphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00887	0.178	CrCbGaD
Tolazoline—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00879	0.00925	CbGpPWpGaD
Tolazoline—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00811	0.00854	CbGpPWpGaD
Tolazoline—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00803	0.00845	CbGpPWpGaD
Tolazoline—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00788	0.00829	CbGpPWpGaD
Tolazoline—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00758	0.00797	CbGpPWpGaD
Tolazoline—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00732	0.00771	CbGpPWpGaD
Tolazoline—Amphetamine—DRD2—Gilles de la Tourette syndrome	0.00712	0.143	CrCbGaD
Tolazoline—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00675	0.0071	CbGpPWpGaD
Tolazoline—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00662	0.00697	CbGpPWpGaD
Tolazoline—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00615	0.00648	CbGpPWpGaD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.005	0.00526	CbGpPWpGaD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00485	0.00511	CbGpPWpGaD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00452	0.00476	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00428	0.00451	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00416	0.00438	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00387	0.00408	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00326	0.00343	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00317	0.00333	CbGpPWpGaD
Tolazoline—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00317	0.00333	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00317	0.00333	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00308	0.00324	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00296	0.00311	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00295	0.0031	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00294	0.00309	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00287	0.00302	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00287	0.00302	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00285	0.003	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00275	0.00289	CbGpPWpGaD
Tolazoline—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00271	0.00286	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00268	0.00282	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00267	0.00281	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00266	0.0028	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00252	0.00265	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00248	0.00261	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00245	0.00258	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00245	0.00257	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0024	0.00253	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0024	0.00253	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00238	0.0025	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00235	0.00248	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00233	0.00246	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00233	0.00245	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00228	0.0024	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00228	0.0024	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00223	0.00235	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00221	0.00233	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00217	0.00229	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00217	0.00229	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00217	0.00228	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00213	0.00224	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0021	0.00221	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00207	0.00217	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00206	0.00216	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00203	0.00214	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00202	0.00212	CbGpPWpGaD
Tolazoline—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.002	0.00211	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.002	0.0021	CbGpPWpGaD
Tolazoline—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00197	0.00207	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00192	0.00202	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00191	0.00201	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0019	0.002	CbGpPWpGaD
Tolazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00186	0.00196	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00186	0.00196	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00186	0.00196	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00186	0.00195	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00184	0.00194	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00179	0.00189	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00179	0.00189	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00179	0.00188	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00176	0.00185	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00174	0.00183	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00174	0.00183	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00173	0.00183	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00173	0.00182	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.00172	0.00181	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00167	0.00176	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00167	0.00175	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00162	0.00171	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00162	0.00171	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0016	0.00168	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0016	0.00168	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00157	0.00165	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00163	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00155	0.00163	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00152	0.0016	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00152	0.0016	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00151	0.00159	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00157	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00146	0.00153	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00144	0.00152	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00142	0.00149	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00141	0.00149	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00141	0.00149	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.0014	0.00147	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00133	0.0014	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00132	0.00139	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0013	0.00137	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00121	0.00128	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00121	0.00127	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00117	0.00123	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00119	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00108	0.00114	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00112	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00105	0.00111	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00101	0.00107	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00106	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000992	0.00104	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000989	0.00104	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000984	0.00104	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000983	0.00103	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00098	0.00103	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00096	0.00101	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000956	0.00101	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000922	0.00097	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000919	0.000968	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000916	0.000964	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000902	0.000949	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000894	0.000941	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000893	0.00094	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00089	0.000937	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000885	0.000932	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000876	0.000922	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000859	0.000904	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000832	0.000875	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000822	0.000866	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000819	0.000862	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000816	0.000859	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000804	0.000846	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000801	0.000843	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000798	0.00084	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000795	0.000837	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00078	0.000821	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000747	0.000786	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000744	0.000783	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000741	0.00078	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000727	0.000765	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000725	0.000763	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000687	0.000723	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000675	0.000711	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000641	0.000675	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000626	0.000659	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000623	0.000656	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000582	0.000613	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000581	0.000612	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000571	0.000601	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000565	0.000594	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000561	0.00059	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000543	0.000572	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000527	0.000555	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000526	0.000553	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000521	0.000548	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000519	0.000546	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000509	0.000536	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000491	0.000517	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000484	0.000509	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000475	0.0005	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000473	0.000498	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00047	0.000494	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000461	0.000485	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000441	0.000464	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000438	0.000461	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000429	0.000452	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000428	0.000451	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000399	0.00042	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000368	0.000388	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000344	0.000362	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000307	0.000323	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000301	0.000317	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000279	0.000294	CbGpPWpGaD
